Epiomic Epidemiology Series: Chronic Pancreatitis Forecast in 23 Major Markets 2018–2028

April 2018 | 74 pages | ID: EBDFC16250BEN
Black Swan Analysis limited

Abstracts

Black Swan Analysis Epiomic Epidemiology Forecast Report on Chronic Pancreatitis in 23 Major Markets

Chronic pancreatitis (CP) is a persistent low-level inflammation of the pancreas involving progressive inflammatory and fibrotic changes in the exocrine parts of the organ. As a result of constant inflammation, scarring and fibrosis of the pancreatic ducts occur, leading to permanent structural damage and impairment the organ’s secretory functions. Eventually, both endocrine and exocrine functions become impaired. CP has a strongly debilitating effect on patients, leading to malnutrition, weight loss and pancreatogenic diabetes, and causing persistent abdominal pain that is difficult to alleviate.

This report provides the current prevalent population for chronic pancreatitis across 23 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Finland, Denmark, Austria, Switzerland, Czech Republic, Hungary, Turkey, Japan, China, South Korea, India, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, chronic pancreatitis patients grouped by aetiology, as well as the main comorbidities of the disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities of chronic pancreatitis include:

• Alcoholism
• Malabsorption with weight loss
• Type 3c diabetes mellitus
• Osteopenia/osteoporosis
• Coeliac disease
• Cystic fibrosis
• Gallstones
• Pancreatic cancer
• Depression

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world-class sources that deliver the most up-to-date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

Ability to quantify patient populations in global chronic pancreatitis market to target the development of future products, pricing strategies and launch plans.

Further insight into the prevalence of the subdivided types of chronic pancreatitis and identification of patient segments with high potential.

Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.

Better understanding of the impact of specific co-morbid conditions on the prevalent population of chronic pancreatitis patients.

Identification of chronic pancreatitis patient sub-populations that require treatment.

Better understanding of the specific markets that have the largest number of chronic pancreatitis patients.

Contents

INTRODUCTION

CAUSE OF THE DISEASE

RISK FACTORS & PREVENTION

DIAGNOSIS OF THE DISEASE

VARIATION BY GEOGRAPHY/ETHNICITY

DISEASE PROGNOSIS & CLINICAL COURSE

KEY COMORBID CONDITIONS / FEATURES ASSOCIATED WITH THE DISEASE

METHODOLOGY FOR QUANTIFICATION OF PATIENT NUMBERS

TOP-LINE PREVALENCE FOR CHRONIC PANCREATITIS

FEATURES OF CHRONIC PANCREATITIS PATIENTS

COMORBIDITIES OF CHRONIC PANCREATITIS PATIENTS

ABBREVIATIONS USED IN THE REPORT

OTHER BLACK SWAN SERVICES & SOLUTIONS

REPORTS & PUBLICATIONS

ONLINE EPIDEMIOLOGY DATABASES

ONLINE PHARMACEUTICAL PRICING DATABASE

REFERENCES

APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Table 1. Prevalence of chronic pancreatitis, total (000s)
Table 2. Prevalence of chronic pancreatitis, males (000s)
Table 3. Prevalence of chronic pancreatitis, females (000s)
Table 4. Patients with chronic pancreatitis by main aetiology, total (000s)
Table 5. Chronic pancreatitis patients with osteopenia, total (000s)
Table 6. Chronic pancreatitis patients with osteoporosis, total (000s)
Table 7. Chronic pancreatitis patients with diabetes mellitus, total (000s)
Table 8. Chronic pancreatitis patients with chronic pain, total (000s)
Table 9. Chronic pancreatitis patients with pancreatic exocrine insufficiency, total (000s)
Table 10. Chronic pancreatitis patients with acute attack pancreatitis, total (000s)
Table 11. Chronic pancreatitis patients with pancreatic calcifications, total (000s)
Table 12. Abbreviations and acronyms used in the report
Table 13. USA prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 14. USA prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 15. Canada prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 16. Canada prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 17. France prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 18. France prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 19. Germany prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 20. Germany prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 21. Italy prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 22. Italy prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 23. Spain prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 24. Spain prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 25. UK prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 26. UK prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 27. Poland prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 28. Poland prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 29. Netherlands prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 30. Netherlands prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 31. Finland prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 32. Finland prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 33. Denmark prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 34. Denmark prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 35. Austria prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 36. Austria prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 37. Switzerland prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 38. Switzerland prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 39. Czech Republic prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 40. Czech Republic prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 41. Hungary prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 42. Hungary prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 43. Turkey prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 44. Turkey prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 45. Japan prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 46. Japan prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 47. China prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 48. China prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 49. South Korea prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 50. South Korea prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 51. India prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 52. India prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 53. Brazil prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 54. Brazil prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 55. Mexico prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 56. Mexico prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)
Table 57. Argentina prevalence of chronic pancreatitis by 5-yr age cohort, males (000s)
Table 58. Argentina prevalence of chronic pancreatitis by 5-yr age cohort, females (000s)